Wednesday, July 8, 2026

pharma · Colorectal Cancer · Esophageal Varices in NASH Cirrhosis · GALT

Galectin Therapeutics

News and analysis for Galectin Therapeutics on NovaPharmaNews — regulatory, clinical, and market coverage.

4960 Peachtree Industrial Boulevard, Suite 240, Norcross, GA 30071, US HQ
2000 Founded
36 Employees
Public company Type
GALT · NYSE Ticker
Company details
Status
Public
HQ
4960 Peachtree Industrial Boulevard, Suite 240, Norcross, GA 30071, US
Founded
2000
Employees
36
Programs
12
Drugs
5
Patents
20
Intelligence · Coverage

News & analysis

NovaPharmaNews articles mentioning Galectin Therapeutics — regulatory, clinical, and market coverage.

News and analysis for Galectin Therapeutics on NovaPharmaNews — regulatory, clinical, and market coverage.

No coverage yet

We have not published news or analysis mentioning Galectin Therapeutics yet.

Back to company overview →